Lymphoma associated molecules and uses therefor

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S023100, C435S007100, C514S04400A

Reexamination Certificate

active

07858742

ABSTRACT:
The invention provides isolated nucleic acids molecules, designated BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a BAL gene has been introduced or disrupted. The invention still further provides isolated BAL proteins, fusion proteins, antigenic peptides and anti-BAL antibodies. Diagnostic methods using compositions of the invention are also provided.

REFERENCES:
patent: 7041814 (2006-05-01), Weinstock et al.
patent: 7112420 (2006-09-01), Shipp et al.
patent: 7393663 (2008-07-01), Edwards et al.
Aguiar et al. The Journal of Biological Chemistry, 2005, vol. 280, p. 33756-33765.
Aguiar et al., “TEL-AML1 fusion in acute lymphoblastic leukaemia of adults,” British Journal of Haematology, 95:673-677 (1996).
Aguiar et al., “Molecular characterization of a tissue-specific protein tyrosine phosphatase (PTP) and putative tumor suppressor which is down-regulated in high risk diffuse large B-cell lymphomas (DLB-CLs),” Blood 90 (Suppl. 1):491a, Abstract 2185 (1997).
Aguiar et al., “The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster,” Leukemia, 11:233-238 (1997).
Aguiar et al., “PTPROt: An Alternatively Spliced and Developmentally Regulated B-Lymphoid Phosphatase that Promotes G0/G1 Arrest,” Blood 94(7):2403-2413 (Oct. 1, 1999).
Bowie et al., “Deciphering the message in protein sequences: tolerance to amino acid substitutions,” Science, 247:1306-1310(1990).
Bretscher et al., “EGF induces recycling membrane to form ruffles,” Current Biology, 8:721-724 (1998).
Burgess et al., “Possible Dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue,” Journal of Cell Biol., 111:2129-2138 (1990).
Cabanillas et al., “Frequent Nonrandom Chromosome Abnormalities in 27 Patients with Untreated Large Cell Lymphoma and Immunoblastic Lymphoma,” Cancer Research, 48:5557-5564 (Oct. 1, 1988).
Lazar et al., “Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities,” Molecular and Cellular Biology, 8(3):1247-1252 (1988).
Liang et al., “Differential Display of Eurkaryotic Messenger RNA by Means of the Polymerase Chain Reaction,” Science, 257:967-971 (Aug. 14, 1992).
Mitelman et al., “A breakpoint map of recurrent chromosomal rearrangements in human neoplasia,” Nature Genetics, 15:417-474 (Apr. 1997).
Monni et al., “Gain of 3q and Deletion of llq22 Are Frequent Aberrations in Mantle Cell Lymphoma,” Genes, Chromosomes & Cancer, 21:298-307 (1998).
Pehrson et al., “Evolutionary conservation of histone macroH2A subtyes and domains,” Nucleic Acids Research, 26(12):2837-2842 (1998).
Schouten et al., “Chromosomal Abnormalities in Untreated Patients with Non-Hodgkin's Lymphoma: Associations With Histology, Clinical Characteristics, and Treatment Outcome,” Blood, 75(9):1841-1847 (1990).
Shipp et al., “A Predictive Model for Aggressive Non-Hodgkin's Lymphoma,” New England Journal of Medicine, 329(14):987-994 (1993).
Warrick et al., “Myosin Structure and Function in Cell Motility,” Ann. Rev. Cell Biol., 3:379-421 (1987).
Yakushijin et al., “A Directly Spliced Exon 10-Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma,” Blood, 91(11):4282-4291 (Jun. 1, 1998).
Adams et al., “Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library,” Nature Genetics, 4(4):373-380 (1993) Abstract.
Bonaldo et al., “Normalization and subtraction: two approaches to facilitate gene discovery,” Genome Research, 6(9):791-806 (1996) Abstract.
Mercer D.W., “Immunoassays for the detection of tumor associated antigens,” In Manual of clinical laboratory immunology, Edited by Rose et al., Washington, D.C. American Society for Microbioloty, 4thEd., pp. 791-795.
Pharmacia, Overview of molecular biology products. Pharmacia Biotech., pp. 107, 110-117, 139, 163-165 (1996).
Zambrowicz et al., Disruption and sequence identification of 2000 genes in mouse embryonic stem cells, Nature, 392:608-611 (Apr. 9, 1998).
Database EMBL Apr. 25, 1998 “AF046630 Mus musculus 129Sv/Ev Mus musculus genomic clone OST8563, DNA sequence,” XP002316474, retrieved from EBI accession No. EM—GSS:AFO46630, Database accession No. AF046630.
Database EMBL Dec. 14, 1996 “mr05c07.r1 Soares mouse 3NbMS Mus musculus cDNA clone Image:596556 5′, mRNA sequence,” XP002316475, retrieved from EBI accession No. EM—EST:AA146363, Database accession No. AA146363.
Database EMBL Oct. 1, 1998, “ud16c02.r1 Soares 2NbMT Mus musculus cDNA clone Image:1446050 5′, mRNA sequence,” XP002316476, retrieved from EBI accession No. EM—EST:AI157103, Database accession No. A1157103.
Database EMBL Sep. 22, 1998 “qc34a12.x1 Soares—pregnant—uterus—NbHPU Homo sapiens cDNA clone Image:1711486 3′, mRNA sequence,” XP002316477, retrieved from EBI accession No. EM—EST:AI129360, Database accession No. AI129360.
Database EMBL Dec. 15, 1996 “z125b01.r1 Soares—pregnant—uterus—NbHPU Homo sapiens CDNA clone Image:502921 5′, mRNA sequence,” XP002316478, retrieved from EBI accession No. EM—EST:AA151346, Database accession No. AA151346.
Yakushijin et al., “Molecular characterization of a novel gene, bal, which regulates the proliferation of aggressive B-cell lymphomas,” Blood, 90(10) Suppl. 1, Part 1, p. 177A, XP008042576.
Hillier et al., “Generation and Analysis of 280,000 Human Expressed Sequence Tags,” Genome Res. 6(9):807-828 (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Lymphoma associated molecules and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lymphoma associated molecules and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphoma associated molecules and uses therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4226828

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.